Development of fast-dissolving dosage forms of curcuminoids by electrospinning for potential tumor therapy application.

Aqueous electrospinning Curcumin Curcuminoids Cyclodextrin Fast-dissolving

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
05 Jan 2022
Historique:
received: 16 07 2021
revised: 24 11 2021
accepted: 25 11 2021
pubmed: 2 12 2021
medline: 24 12 2021
entrez: 1 12 2021
Statut: ppublish

Résumé

Curcuminoids (CUs) of antitumor and various other potential biological activities have extremely low water solubility therefore special formulation was elaborated. New fast dissolving reconstitution dosage forms of four CUs were prepared as fibrous form of 2-hydroxypropyl-β-cyclodextin (HP-β-CD). In the electrospinning process HP-β-CD could act both as solubilizer and fiber-forming agent. The solubilization efficiency of the CU-HP-β-CD systems was determined with phase-solubility measurements. The electrospun CUs were amorphous and uniformly distributed in the fibers according to XRD analysis and Raman mappings. The fibrous final products had fast (<5 min) and complete dissolution. In typical iv. infusion reconstitution volume (20 mL) fibers containing 40-80 mg of CU could be dissolved, which is similar to the currently proposed dose (<120 mg/m

Identifiants

pubmed: 34852289
pii: S0378-5173(21)01133-9
doi: 10.1016/j.ijpharm.2021.121327
pii:
doi:

Substances chimiques

Diarylheptanoids 0
Excipients 0
Hypromellose Derivatives 3NXW29V3WO

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121327

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Krisztina Kiss (K)

Department of Organic Chemistry and Technology, Budapest University of Technology and Economics (BME), H-1111 Budapest, Hungary; ELKH-ELTE Research Group of Peptide Chemistry, Eötvös Loránd University, H-1117 Budapest, Hungary; Tavanta Therapeutics Hungary Zrt., H-1138 Budapest, Hungary.

Kristóf Hegedüs (K)

Institute of Organic Chemistry, Research Centre for Natural Sciences, H-1111 Budapest, Hungary.

Panna Vass (P)

Department of Organic Chemistry and Technology, Budapest University of Technology and Economics (BME), H-1111 Budapest, Hungary. Electronic address: panna.vass@oct.bme.hu.

Diána Vári-Mező (D)

National Institute of Oncology, Department of Experimental Pharmacology, H-1122 Budapest, Hungary.

Attila Farkas (A)

Department of Organic Chemistry and Technology, Budapest University of Technology and Economics (BME), H-1111 Budapest, Hungary.

Zsombor Kristóf Nagy (ZK)

Department of Organic Chemistry and Technology, Budapest University of Technology and Economics (BME), H-1111 Budapest, Hungary.

László Molnár (L)

Tavanta Therapeutics Hungary Zrt., H-1138 Budapest, Hungary.

József Tóvári (J)

National Institute of Oncology, Department of Experimental Pharmacology, H-1122 Budapest, Hungary.

Gábor Mező (G)

ELKH-ELTE Research Group of Peptide Chemistry, Eötvös Loránd University, H-1117 Budapest, Hungary; Institute of Chemistry, Eötvös Loránd University, H-1117 Budapest, Hungary.

György Marosi (G)

Department of Organic Chemistry and Technology, Budapest University of Technology and Economics (BME), H-1111 Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH